小分子化合物扩增造血干细胞的研究进展
被引量:3
Small-molecular compounds to expand hematopoietic stem cells
摘要
应用骨髓移植治疗白血病等恶性血液疾病已有50多年的历史。但骨髓中造血干细胞(Hsc)数量较低,移植后难以在患者体内有效进行造血重建,这也成为HSC临床应用的一个瓶颈。之前研究者曾采用加入多种细胞因子的液体培养基、与基质细胞共同培养或在生物反应器中培养等方法体外扩增造血干,祖细胞(HSPC),但上述方法仍不能获得充足的具有植活能力的HSPC用于临床治疗。
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2014年第1期82-85,共4页
Chinese Journal of Hematology
基金
国家自然科学基金(81170465)
参考文献39
-
1Nishino T,Osawa M,Iwama A. New approaches to expand hematopoietic stem and progenitor cells[J].Expert Opinion on Biological Therapy,2012,(06):743-756.
-
2Walasek MA,van Os R,de Haan G. Hematopoietic stem cell expansion:challenges and opportunities[J].Annals of the New York Academy of Sciences,2012.138-150.
-
3Zhang Y,Li W,Laurent T. Small molecules,big roles-the chemical manipulation of stem cell fate and somatic cell reprogramming[J].Journal of Cell Science,2012,(Pt 23):5609-5620.
-
4Boitano AE,Wang J,Romeo R. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells[J].Science,2010,(5997):1345-1348.
-
5Singh KP,Casado FL,Opanashuk LA. The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations[J].Biochemical Pharmacology,2009,(04):577-587.
-
6Ying QL,Wray J,Nichols J. The ground state of embryonic stem cell self-renewal[J].NATURE,2008,(7194):519-523.
-
7Li W,Zhou H,Abujarour R. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2[J].STEM CELLS,2009,(12):2992-3000.
-
8Perry JM,He XC,Sugimura R. Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion[J].Genes & Development,2011,(18):1928-1942.
-
9Huang J,Nguyen-McCarty M,Hexner EO. Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways[J].Nature Medicine,2012,(12):1778-1785.
-
10Chen C,Liu Y,Liu R. TSC-mTOR maintains quiescence and function of hematopoietic stem ceils by repressing mitochondrial biogenesis and reactive oxygen species[J].Journal of Experimental Medicine,2008,(10):2397-2408.
同被引文献41
-
1刘颖中,钟雁,王亚娟.湿疹-血小板减少紫癜综合征1例报告及文献复习[J].中国当代儿科杂志,2006,8(6):499-501. 被引量:5
-
2Braun C J, Boztug K, Paruzynski A, et al. Gene therapy for Wiskott-Aldrich syndrome-long-term efficacy and genotoxicity [J]. Sci Transl Med, 2014, 6(227):227 ra33.
-
3Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome [J]. J Allergy Clin Immunol, 2006, 117(4): 725-738; quiz 739.
-
4Buchbinder D, Nugent D J, Fillipovich AH. Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treat- ments[Jl. Appl Clin Genet, 2014, 7: 55-66.
-
5Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott- Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation [ J ]. Blood, 2004, 104 ( 13 ) :4010-4019.
-
6Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, et al. Long- term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the Europe- an Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation [J]. Blood, 2008, 111 ( 1 ): 439-445.
-
7Proust A, Guillet B, Pellier I, et al. Recurrent V75M mutationwithin the Wiskott-Aldrich syndrome protein: description of a homozygous female patient [J]. Eur J Haematol, 2005, 75 ( 1 ): 54-59.
-
8Massaad MJ, Ramesh N, Geha RS. Wiskott-Aldrich syndrome: a comprehensive review [J]. Ann N Y Acad Sci, 2013, 1285:26- 43.
-
9Ariga T. Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features[J]. Allergol Int, 2012, 61(2):183-189.
-
10Gublcsy V, Mar6di L. Wiskott-Aldrich syndrome [J]. Orv Hetil, 2008, 149(29): 1367-1371.
引证文献3
-
1马宏炜,刘丽辉,徐数娜,胡文青,马永涛,张永清.HLA单倍体相合造血干细胞移植治疗Wiskott-Aldrich综合征一例报告及文献复习[J].中华血液学杂志,2014,35(11):1027-1029. 被引量:2
-
2张静,施均,李星鑫,邵英起,刘持佳,葛美丽,黄振东,聂能,黄金波,郑以州.一个血小板平均体积正常的Wiskott—Aldrich综合征家系调查及基因突变分析[J].中华血液学杂志,2015,36(9):754-758.
-
3连晓岚,胡海燕,许言午,龚张斌,张学礼,冯荣,张丽娜.熟地甘露三糖对小鼠骨髓造血干/祖细胞体外扩增的影响[J].时珍国医国药,2019,30(7):1590-1591. 被引量:9
二级引证文献11
-
1刘阳阳,张学兰,孔庆悦,郑文华,杨雨思,王玲,陈鑫凤.生地黄与熟地黄补血与免疫调节作用研究[J].中药材,2022,45(8):1853-1856. 被引量:19
-
2王敏,屈丽君,汪俭.Wiskott-Aldrich综合征2例临床特征和基因分析[J].临床荟萃,2015,30(8):924-927. 被引量:1
-
3师丽晓,罗丹青,师晓东,李君惠,钟笛萧.异基因造血干细胞移植治疗Wiskott-Aldrich综合征1例报道并文献复习[J].中国医刊,2017,52(6):56-60. 被引量:1
-
4陈青垚,王小平,雷星,高亚珍,徐杰,王梁凤,王芳,杨明.辅料砂仁、陈皮对熟地黄炮制前后化学成分的影响研究[J].中草药,2021,52(20):6168-6177. 被引量:4
-
5杨校,柯于鹤,李新成.李新成治疗肿瘤化疗相关血小板减少症经验[J].TMR经典中医研究,2022,5(1):14-21.
-
6张杰,倪广晓,王翠侠.从和血生络论治缺血性卒中探析[J].中医临床研究,2022,14(11):43-45.
-
7韦海敏,刘威利,钟文露,向少伟.中医药治疗肾性贫血的研究进展[J].中国民族民间医药,2022,31(14):87-91. 被引量:4
-
8卢兴美,钟凌云,王硕,邓延文,刘洪,陈明霞,黄艺,童恒力.基于UHPLC-LTQ-Orbitrap MS分析不同炮制工艺对地黄化学成分的影响[J].中国中药杂志,2023,48(2):399-414. 被引量:8
-
9王凯悦,王宇,常惠,张蓓,吴效科.基于数据挖掘技术探讨补益类中药治疗早发性卵巢功能不全的用药规律[J].广东药科大学学报,2023,39(6):77-84.
-
10祁昱彤,张淼,刘建勋,孟硕,任钧国.中药地黄的现代研究进展及其质量标志物(Q-marker)预测分析[J].中华中医药学刊,2023,41(12):176-184. 被引量:4
-
1杨仁池.糖皮质激素治疗血液疾病临床经验[J].中国实用内科杂志,2013,33(10):779-781. 被引量:12
-
2彭芸,杨建一,李莉.脐血造血干细胞移植的研究进展及伦理学讨论[J].护理研究,2003,17(02A):140-141. 被引量:4
-
3张东华.慢性粒细胞白血病的骨髓移植治疗[J].中国医刊,1999,34(9):14-16.
-
4楼方定.骨髓移植治疗急性白血病的最新进展[J].中国实用内科杂志,2000,20(1):43-45. 被引量:2
-
5江岷,陈虎,王波,胡亮钉,秦茂权.急性早幼粒细胞白血病缓解后的骨髓移植治疗[J].中华血液学杂志,1998,19(8):434-435. 被引量:3
-
6钱玲玲,蒋秀美,陆化.接受中心静脉导管置入的恶性血液疾病患者中导管相关性血栓的研究进展[J].国际输血及血液学杂志,2016,39(3):260-263. 被引量:2
-
7孙新,刘莎,赵喆,郝文革,廖灿,郭乃榄.脐血移植治疗小儿恶性和非恶性血液疾病的临床研究[J].中国基层医药,2003,10(6):484-487.
-
8李续建,楼方定.造血干细胞移植术发展史[J].中华医史杂志,2001,31(2):96-99. 被引量:2
-
9孟爱民,李德冠,张恒.造血干细胞衰老与临床转化研究[J].中国药理通讯,2010,27(2):21-22.
-
10居小萍,王健民,章卫平,宋献民,陈莉,黄正霞.移植后早期免疫重建与急性移植物抗宿主病关系的研究[J].中国实验血液学杂志,2001,9(4):350-353. 被引量:4